New Times,
New Thinking.

  1. Politics
  2. The Staggers
13 December 2012updated 07 Sep 2021 11:55am

Why is Andrew Neil so keen to bash the New Statesman?

Spectator chairman uses BBC platform

By New Statesman

During an interview with Harriet Harman on today’s edition of BBC2’s Daily Politics, presenter Andrew Neil took an unprompted swipe at the New Statesman, asking the Labour deputy leader: “What’s the logic of saying that the online site of the New Statesman should come within this regulation, a site which has no great influence in Westminster, but that Guido Fawkes, probably the most influential site in Westminster, should not?”

Neil previously interviewed Guido on the programme (29 November) and allowed him to falsely claim that his site attracted more traffic than the New Statesman. Last week, the NS site had 229,472 visitors and 594,710 page views, compared to Guido’s 125,395 visitors and 586,147 page views.

But then Neil is hardly a disinterested party. He is currently chairman (formerly chief executive) of Press Holdings, the company that owns the Spectator magazine, so perhaps it’s not surprising that his usually forensic mind let him down on this occasion. Based on the most recently published figures, the Spectator website, which includes Guido Fawkes blogger Harry Cole among its contributors, attracted just 380,000 unique users a month in 2011.

If Neil wants to use his BBC platform to do down the NS, he should at least declare his interest in doing so.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines